CIK 0001104506
- Large accelerated filer
INSMED Inc
Sign in to watch- Ticker
- INSM
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- VA
- Entity type
- Operating
- EIN
- 541972729
- Phone
- +1 908-977-9900
- Business address
- 700 US HIGHWAY 202/206, BRIDGEWATER, NJ, 08807
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $17,785,602
- in 2 filings, $14.7M under 10b5-1 plans
Net −$17,785,602. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-01-10 | Adsett Roger Chief Operating Officer | Sale 10b5-1 | −3,536 | $28.90 | $102K | 153,810 |
| 2024-01-09 | Wise John Drayton Chief Commercial Officer | Sale | −1,861 | $28.78 | $54K | 113,829 |
| 2024-01-09 | Smith Michael Alexander General Counsel, Senior VP | Sale | −2,373 | $28.76 | $68K | 86,364 |
| 2024-01-09 | Schaeffer Orlov S Nicole Chief People Strategy Officer | Exercise or conversion 10b5-1 | +503 | $20.49 | $10K | 105,652 |
| 2024-01-09 | Schaeffer Orlov S Nicole Chief People Strategy Officer | Sale 10b5-1 | −503 | $29.56 | $15K | 105,149 |
| 2024-01-09 | Schaeffer Orlov S Nicole Chief People Strategy Officer | Sale 10b5-1 | −3,165 | $28.74 | $91K | 101,984 |
| 2024-01-09 | Schaeffer Orlov S Nicole Chief People Strategy Officer | Exercise or conversion · Stock Option (right to buy) 10b5-1 | −503 | 0 | ||
| 2024-01-09 | Flammer Martina M.D. Chief Medical Officer | Sale 10b5-1 | −4,715 | $29.01 | $137K | 112,810 |
| 2024-01-09 | Bonstein Sara Chief Financial Officer | Sale | −4,497 | $29.18 | $131K | 114,051 |
| 2024-01-09 | Adsett Roger Chief Operating Officer | Sale 10b5-1 | −3,837 | $29.25 | $112K | 157,346 |
| 2024-01-09 | Lewis William Chair and CEO | Sale 10b5-1 | −9,887 | $28.72 | $284K | 363,651 |
| 2024-01-08 | Lewis William Chair and CEO | Exercise or conversion 10b5-1 | +24,951 | $20.49 | $511K | 398,489 |
| 2024-01-08 | Lewis William Chair and CEO | Sale 10b5-1 | −24,951 | $29.11 | $726K | 373,538 |
| 2024-01-08 | Lewis William Chair and CEO | Exercise or conversion 10b5-1 | +20,169 | $20.49 | $413K | 393,707 |
| 2024-01-08 | Lewis William Chair and CEO | Sale 10b5-1 | −20,169 | $29.88 | $603K | 373,538 |
| 2024-01-08 | Lewis William Chair and CEO | Exercise or conversion · Stock Option (right to buy) 10b5-1 | +45,120 | $20.49 | $925K | 0 |
| 2024-01-05 | Wise John Drayton Chief Commercial Officer | Sale 10b5-1 | −1,167 | $29.32 | $34K | 115,690 |
| 2024-01-05 | Smith Michael Alexander General Counsel, Senior VP | Sale | −627 | $29.31 | $18K | 88,737 |
| 2024-01-05 | Schaeffer Orlov S Nicole Chief People Strategy Officer | Sale | −1,457 | $29.28 | $43K | 105,149 |
| 2024-01-05 | Lewis William Chair and CEO | Sale | −6,979 | $29.26 | $204K | 373,538 |
Page 43 of 54 · 1,061 trades